FindTrial
Sign In

Does NoL-monitoring influence the intraoperative opioid requirement during da Vinci-prostatectomies?

Does NoL-monitoring influence the intraoperative opioid requirement during da Vinci-prostatectomies?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023232
Enrollment
50
Registered
2020-11-03
Start date
2020-11-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R52.0

Interventions

Group 1: INT group (Sufentanil administration in context of NoL) Group 2: Group CONT (Control group - Sufentanil administration depending on anaesthesiologists decision)

Sponsors

Technische Universität Dresden Universitätsklinikum Carl Gustav Carus Klinik und Poliklinik für Anästhesiologie und Intensivtherapie
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Male, da Vinci-Prostatectomie, sinus rhythm

Exclusion criteria

Exclusion criteria: Cardiac arrhythmia, non legal competent adult, missing consent

Design outcomes

Primary

MeasureTime frame
Sufentanil administration intraoperativ—

Secondary

MeasureTime frame
NRS postoperative, Nausea postoperative—

Countries

Germany

Contacts

Public ContactFelix Niebhagen

Klinik und Poliklinik für Anästhesiologie, Uniklinikum Dresden

Felix.Niebhagen@uniklinikum-dresden.de0351-458-11634

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026